Patients who receive chimeric antigen receptor (CAR) T-cell therapy or allogeneic stem cell transplants (allo-SCT) often exhibit some form of immunosuppression as a result of their treatment or transplant. In the era of COVID-19, severe…
Dr. Lauren WeinandJune 2, 2022
CAR T-cell therapy has gained attention as an increasingly promising cellular therapy. However, while CAR T-cells are highly targeted and effective treatments for certain cancers, they often face mounting obstacles from the tumor microenvironment (TME).…
Dr. Lauren WeinandJune 2, 2022